VOR Stock Price
Vor Biopharma Inc.
VOR stock price is $18.75 (-1.63% on the day), giving Vor Biopharma Inc. a market cap of $1.11B. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
VOR Stock Overview
- Price
- $18.75
- Previous close
- $19.06
- Open
- $18.79
- Market cap
- $1.11B
- P/E ratio
- -1.6
- 52-week range
- $6.50 - $33.42
- 1-year price target
- $37.43
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 35
About Vor Biopharma Inc.
Vor Biopharma Inc. operates as a clinical-stage cell and genome engineering company. Its lead product is tremtelectogene empogeditemcel (trem-cel), an engineered hematopoietic stem cell (eHSC) product candidate that is in phase 1/2 trial to treat acute myeloid leukemia (AML) and other hematological malignancies. The company is also developing Mylotarg, a CD33-directed antibody drug conjugate (ADC) therapy for patients with leukemia; VCAR33, a CAR-T therapy designed to target CD33, a clinically validated target for AML, which are under preclinical and Phase 1/2 clinical studies; trem-cel + VCAR33 treatment system that is under preclinical studies for the treatment of AML; and CD33-CLL1 treatment system made with CD33-CLL1 multiplex-engineered eHSC and CD33-CLL1 multi-specific CAR-T, which are under preclinical studies for the treatment of AML. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VOR | $18.75 | -1.6% | 926.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |